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Ventricular Defibrillation and Cardiac Function. Introduction: The effect of implantable
detibrillator shocks on cardiac hemodynamics is poorly understood. The purpose of this study was
to test the hypothesis that ventricular defibrillator shocks adversely effect cardiac hemodynamics.
Methods and Results: The cardiac index was determined by calculating the mitral valve in-
flow with transesophogeal Doppler during nonthoracotomy defibrillator implantation in 17 pa-
tients. Tbe cardiac index was determined before, and immediately, 1 minute, 2 minutes, and 4
minutes after sbocks were delivered during defibrillation energy requirement testing with 27-
to 34-, 15-, I0-, 5-, 3-, or 1-J shocks. Tbe cardiac Index was also measured at tbe same time
points after 27- to 34-, and 1-J sbocks delivered during tbe baseline rhytbm. Tbe cardiac index
decreased from 2.30 ± 0.40 L/min per m- before a 27- to 34-J sbock during defibrillation en-
ergy requirement testing to 2.14 ± 0.45 L/min per m- immediately afterwards (P = 0.001). Tbis
effect persisted for > 4 minutes. An adverse bemodynamic effect of similar magnitude occurred
after 15 J (P = 0.003) and lO-J sbocks (P = 0.01), but dissipated after 4 minutes and witbin 2
minutes, respectively. Tbere was a significant correlation between sbock strength and the per-
cent cbange in cardiac index (r = 0.3, P = 0.03). The cardiac index decreased 14% after a 27- to
34-J sbock during tbe baseline rhytbm (P < 0.0001). Tbis eflect persisted for < 4 minutes. A 1-
J sbock during tbe baseline rhytbm did not effect the cardiac index.
Conclusion: Defibrillator sbocks > 9 J delivered during tbe baseline rbytbm or during defi-
brillation energy requirement testing result in a 10% to 15% reduction in cardiac index,
wbereas smaller energy sbocks do not affect cardiac bemodynamics. Tbe duration and extent
of tbe adverse effect are proportional to tbe sbock strengtb. Sbock strengtb, and not ventricu-
lar fibrillation, appears to be most responsible for tbis effect. Tberefore, the detrimental hemo-
dynamic effects of high-energy sbocks may be avoided wben low-energy defibrillation is used.
(J Cardiovasc Electrophysiol, Vol. 9, pp. 791-797. August 1998)
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Introduction
Ventricular implantable defibrillators frequently
are programmed to deliver the maximum shock
energy, irrespective of the defibrillation energy re-
quirement. However, the effect of ventricular im-
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plantable defibrillator shock strength on cardiac
hemodynamics has not been well defined.' "̂  There-
fore, the purpose of this study was to test the hy-
pothesis that nonthoracotoiny ventricular defibril-
lator shocks adversely affect cardiac hemodynamics.
Methods
Patient Population
The study population cotisisted of 17 patients
(12 men and 5 women; mean age 55 ± 16 years)
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undergoing implantation of a transvenous im-
plantable cardioverter defibrillator. Eigbt patients
had coronary artery disease. 8 patients had a non-
ischemic cardiomyopathy, and I patient had no
structural heart disease. The mean left ventricular
ejection fraction was 0.32 ±0.12 (range 0.15 to
0.55). and 4 patients had an ejection fraction > 0.40.
Tbe mean New York Heart Association Conges-
tive Heart Failure Class was 1.9 ± 0.7 {range Class
I to III). The baseline rhythm was sinus in 14 pa-
tients and atrial fibrillation in 3. Transesophageal
Doppler ecbocardiography was used to determine
mitral valve inflow (see following). Cardiac out-
put equals cardiac inflow only in tbe absence of
significant mitral regurgitation. Therefore., patients
were evaluated preoperatively for mitral regurgi-
tation with either cardiac catheterization or with
two-dimensional surface echocardiography. Patients
with more than minimal echocardiographically ev-
ident mitral regurgitation were not eligible for par-
ticipation in the study protocol.
Defibrillator System and Implantation
All patients came to the operating room in a
postabsorptive state. Therapy with antiarrhythmic
medications was discontinued at least five half-lives
prior to device implantation, except in eight patients
in whom amiodarone therapy had been ineftective.
Angiotensin-converting enzyme inhibitor therapy,
calcium channel blocker therapy, beta-blocker ther-
apy, and digoxin were continued in II, 1, 4, and
10 patients, respectively. General anesthesia was
induced., the patients were intubated, and a constant
level of anesthesia was maintained throughout the
implant procedure and study protocol using sup-
plemental doses of inhalational agents, fentanyl and
its derivatives, or a steroid anesthetic.
A transvenous dual coil defibrillation lead was
implanted in 16 patients (models 75, 115, and 125,
Cardiac Pacemakers, Inc. [CPIl, St. Paul, MN,
USA). A transvenous defibrillation lead with a sin-
gle shocking electrode (model 6936, Medtronic
Inc., Minneapolis, MN, USA) was used in one pa-
tient. The defibrillation lead was positioned in
tbe right ventricular apex via the subclavian vein
under tluoroscopic guidance.
Sixteen of tbe patients in this study received a
defibrillator with a truncated, fixed-tilt bipbasic
wavefomi with a first phase tilt of 60% and a sec-
ond phase tilt of 50% (models 1720, 1725, 1740,
1742, 1743, 1762, and 1763, CPI), and one patient
received a defibrillator with a first phase tilt and
second phase tilt of 65% (model 7219C, Medtronic,
Inc.). The defibrillator shell functioned as a defi-
briiiation electrode in six patients.
Study Protocol
Written informed consent was obtained under a
protocol approved by the Human Research Com-
mittee at the University of Michigan. All shocks
were delivered directly from the implantable de-
fibrillator. Shocks were delivered during the
baseline rbythm and during defibrillation energy
requirement testing. Shocks were delivered during
the baseline rhytbm to assess the isolated effect of
a shock, in the absence of ventricular fibrillation,
on cardiac function. In this way, tbe effects of a
shock can be separated from the effects of ven-
tricular fibrillation. A 1 -J shock and tben a 27- to
34-J shock (tbe maximum energy delivered by tbe
implantable defibrillator) were delivered synchro-
nized to the QRS complex during the baseline
rhythm.
A step-down protocol was then utilized to de-
termine the defibrillation energy requirement. The
defibrillation energy requirement was defined as
the lowest energy successful at converting ven-
tricular fibrillation to the baseline rhythm. Shock
energies of 15, 10. 5, 3. and 1.0 J were delivered
until ventricular fibrillation failed to convert to the
baseline rhythm. If tbe 15-J shock was ineffective,
the first shock lor the subsequent induction was
20 J. A 27- to 34-J defibrillator shock was also
used to convert ventricular fibrillation to the base-
line rhythm. Ventricular fibrillation was induced
with ventricular pacing with a 15-V pulse deliv-
ered every 30 msec with a duration of 1.1 msec
for I to 3 seconds. The mean duration of ventric-
ular fibrillation was 12.7 ± 3.9 seconds for maxi-
mum energy shocks, 9.5 ± 0.5 seconds for 20-J
shocks, 8.3 ± 1.8 seconds for 15-J shocks, 7.4 ±
1.9 seconds for 10-J shocks, and 6.7 ± 1.8 seconds
for shocks < 10 J (P < O.OOOI)- At least 5 min-
utes was allowed to elapse between shocks deliv-
ered during the baseline riiythm iind between shocks
that resulted in successful defibrillation.
Cardiac Output Measurement
The cardiac output was estimated using a mea-
sure of mitral valve inflow.'"̂  This technique cor-
relates well with the caidiac output detennined with
conventional tbermodilution techniques'' and offers
the advantage of providing an assessment of beat-
by-beat changes in cardiac output. Conventional
thermodilution techniques cannot be used to assess
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rapid changes because several measurements over
approximately 2 to 3 minutes are required.
After induction of general anesthesia but before
defibrillator implantation, a transesophageal echo-
cardiography probe was inserted. The probe was
positioned to optimize visualization of mitral in-
flow in a basal four-chamber view.̂  During the
protocol, the same standard view of the mitral valve
was maintained to ensure consistency of the
color flow Doppler interrogation. At baseline, the
diameter of the mitral annulus was determined in
one plane. Pulsed-wave Doppler was used to de-
fine left ventricular inflow at the level of the mi-
tral valve annulus.*^̂  Scale and sweep speed were
optimized for subsequent quantitation of the ve-
locity time integral. Based on the assumption that
left ventricular inflow equals left ventricular out-
flow (cardiac output) in the absence of mitral re-
gurgitation, transmitral inflow was calculated as
an estimate of cardiac output using the mitral an-
nular cross-sectional area, flow at the level of the
mitral annulus, and heart rate."̂  Pulsed-wave Doppler
at the level of the mitral annulus was performed
at baseline and was repeated immediately after
each shock. All images were recorded on standard
VHS videotape for subsequent off-line analysis.
Images were digitized from videotape using com-
mercially available hardware and software (TomTec
Imaging Systems, Inc., Boulder, CO, USA). The
velocity time integral of left ventricular inflow was
averaged for at least five consecutive cycles in all
patients; 10 cycles were used for patients with atrial
fibrillation. Mitral inflow velocities associated with
premature ventricular complexes, post premature
ventricular complexes, and ventricular paced
beats were excluded from analysis. Shocks were
delivered within 30 seconds of recording the
baseline mitral inflow. The mean time to comple-
tion of the first mitral valve inflow determination
after each shock was 19.7 ± 10.8 seconds.
All measurements for mitral inflow velocity time
integral were detennined independently by three
investigators. Two of the three investigators were
blinded to the shock energy and the rhythm. The
mean variability of these measurements was 10.7%
± 6.6%. The values determined by all investiga-
tors were averaged, and the means were used for
analysis.
variables were compared by ANOVA, and then by
individual paired /-tests when the ANOVA result
was stati.Stic ally significant. The relationship be-
tween two continuous variables was assessed with




The mean defibrillation energy requirement was
8.6 ± 4.8 J in the 17 patients. The defibrillation
energy requirement was 20 J in 1 patient, 15 J in
2, 10 J in 6, 5 J in 6. and 3 J in 2. In one patient
with a 5-J defibrillation energy requirement, a
recording malfunction precluded the determination
of the Doppler measurement. Because of the small
number of successful defibrillations with energies
< 10 J, these data were analyzed as a single group.
Effect of Shocks During Defibrillation Energy
Requirement Testing
The cardiac index decreased from 2.30 ± 0.40
L/min per m̂  before a 27- to 34-J shock (n = 16)
during deflbrillation energy requirement testing
to 2.14 ± 0.45 LVmin per m- immediately after the
shock (P = 0.001; Figs. 1 and 2). The cardiac in-
dex remained depressed for > 4 minutes (P < 0.01).
After a 15-J shock (n = 17) during defibrillation
energy requirement testing, the cardiac index de-
creased from 2.32 ± 0.44 L/min per m- to 2.17 ±
0.41 L/min per m^ (Table 1; P < O.OI). and re-
mained depressed for > 4 minutes (P = 0.04). A
10-J shock (n = 14) resulted in an immediate de-
crease of 6% in the cardiac index that reversed
within 2 minutes (Table 1; P = 0.02). Successful
deflbrillation with shocks < 10 J (n = 9) was not
associated with a decreased cardiac index (Table
1; P = 0.8). With shocks of 10 J and greater, the
nadir of the cardiac index was noted I minute af-
ter the deflbrillation shock (Table 1). The percent
change in cardiac index correlated negatively with
shock strength (Fig. 3; r = 0.3, P = 0.03). The
change in cardiac index associated did not corre-
late with the duration of ventricular fibrillation or
with the ejection fraction.
Statistical Analysis
Continuous variables are expressed as mean ±
1 SD and were compared using a paired or un-
paired /-test, as appropriate. Multiple continuous
Effect of Shocks During Baseline Rhythm
A 27- to 34-J shock synchronized to the QRS
complex during the patients' baseline rhythm (n =
14) resulted in the cardiac index decreasing from








Baseline 0.3 min I min 2 min 4 min
Time After Conversion
Figure 1. Cardiac Index and 27- to 34-J shocks. The mean
effects of a 27- to 34-J shock delivered during defihrillation
energy requirement testing are shown. Cardiac inde.\ (CI)
is represented on the y-axis. and time is repre.sented on the
X-axis. *P <0.01; +P < 0.05.
2.32 ± 0.33 L/min per m̂  to 2.00 ± 0.33 L/min
per m- immediately after the shock (Table 1; P <
0.0001). This effect persisted for < 4 minutes. A
1-J shock delivered during the baseline rhythm (n
= 15) did not affect the cardiac index (Table 1).
The relative magnitude of change in the stroke vol-
ume was not different after a 27- to 34-J shock de-
livered to treat ventricular fibrillation or when
delivered during the baseline rhythm (11.7% ±
6.4% vs 11.6% ± 5.8%, P = 1.0).
The effect of deflbrillation on stroke volume
was nearly identical to the changes noted in car-
diac index (Table 2). Heart rate was largely unaf-
fected by the defibrillation shocks (Table 3).
Discussion
Major Findings
Biphasic implantahle defibrillator shocks of 10
J or more delivered during the baseline rhythm
or when used to terminate ventricular fibrillation
result in a 10% to 15% reduction of cardiac index,
which occurs secondary to a reduction in stroke
volume. With 27- to 34-J shocks delivered dur-
ing defibrillation energy requirement testing, the
cardiac index returns to normal after 4 minutes,
whereas when 27- to 34-J shocks are delivered
during the baseline rhythm, the adverse hemody-
namic effect dissipates within 4 minutes. The du-
ration and extent of the adverse hemodynamic
effect are proportional to the shock strength.
Mechanism of Shock Effect
The detrimental hemodynamic effect of a ven-
tricular defibrillator shock appears to be due to the
shock itself, and not to ventricular fibrillation. Be-
cause a similar degree of ventriculai" stunning was
noted after shocks delivered during the baseline
rhythm as with shocks that tenninated ventricular
fibrillation, one must conclude that the shocks cause
the stunning. This statement is supported by the
fact that 27- to 34-J shocks delivered during ven-
tricular fibrillation or during the baseline rhythm
resulted in similar reduction in the cardiac index,
although the adverse hemodynamic effect of shocks
Baseline 35 sec mtn mm 4 min
11)0 1
VTI(cm) 14.1 12.0 1.7 12.1
Figure 2. Doppler signat during defibriiiation energy requirement testing. An example of the Doppler signals (cm/sec) ob-
tained after a 29-J shock was detivered during defihrittation energy requirement testing is stwwn. The basetine signal is on
the left, followed by the signals obtained 35 seconds. 1 minute. 2 minutes, and 4 minutes after the shock. The mitral valve ve-
locity time integral fVTI) value is recorded directly beneath each Doppter signat. In this exampte. a 14% reduction of the mi-
trat valve velocity time integral was observed 35 .seconds after the shock. Ttie nadir of the mitral valve velocity time integrat
was achieved 2 minutes after the shock.
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CI = cardiac index; DER = defibrillation energy requirement; SR = baseiine rhythm.
*P < 0.01: t P < 0.05.
delivered during defibriliation testing lasted longer
than the hemodynamic effect of shocks delivered
during the baseline rhythm. If the stunning effect
was primarily due to ventricular fibrillation, changes
in cardiac index with shocks delivered during the
baseline rhythm would not be expected.
The influence of ventricular fibrillation on these
results may be difficult to separate from the ef-
fect of shocks because larger shocks required longer
charge times and. hence, longer durations of ven-
tricular fibrillation. At a minimum, one can con-
clude that the shorter duration of ventricular fi-
brillation associated with shock energies < 10 J
are not lotig enough to affect cardiac hemody-
namics. This supports the concept that shock
strength and, to a lesser extent, ventricular fibril-










































Figure 3. Shock sirenglh and cardiac index. A significant
relationship hetween shock strength and the percent
change in the cardiac index (CI) was noted. Individual pa-
tient data are denoted by an X.
Doppler Cardiac Output Technique
The cardiac output in the present study was
estimated using a Doppler measure of mitral valve
inflow.̂ ^ The measurements were made indepen-
dently by three investigators, and the mean values
were associated with an interobserver variability
of 10%. The mean paired data were compared and
significant changes were noted. Additionally, when
the data from each individual observer were ana-
lyzed independently, similar findings were obtained.
A possible limitation of the Doppler technique
is that the mitral annular orifice is known to be
"saddle-shaped" and to change throughout the car-
diac cycle. Although using a simplified assumption
of a circular annular shape may result in errors in
the absolute quantitation of cardiac output, any such
errors should be constant among individual patients
and differences between shocks should still reflect
true differences in cardiac output.
Previous Studies
The results of animal studies suggested that ex-
temal and epicardial shocks synchronized to the QRS
complex are associated with reduced systolic and
diastolic function.** " More recently, the severity of
systolic and diastolic dysfunction noted after defi-
brillation was found to be related to the shock strength
in an animal model.'- In humans, transthoracic shocks
given to treat ventricular tachycardia or atrial fibril-
lation are associated with systolic and diastolic dys-
function.'̂  When ventricular tachycardia was ter-
minated with burst pacing, a change in cardiac per-
formance was not observed." These results
support the concept that shocks, regardless of the
heart rhythm, adversely alter ventricular function.
The effect of implantabie defibrillator shocks
on cardiac hemodynamics in humans has var-
ied.''' The inconsistent findings of the previous
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DER = defibrillation energy requirement: SR = baseline rhythm: SV = stroke volume.
*P< 0.01; t p < 0.05.
reports probably are due to several reasons., in-
cluding the use of different waveforms and lead
systems, small sample sizes, noninstantaneous
techniques for measuring stroke volume, and in-
consistent reporting of shock strengths.'"^ Two pre-
vious studies have assessed the effect of im-
plantable defibrillator shocks on cardiac hemo-
dynamics using a transvenous lead system.^"*
The results of these two studies differ significantly
from those of the present study. One of the stud-
ies combined data from patients with monopha-
sic and biphasic waveforms and epicardial and
transvenous lead systems, did not include shock
strength data, assessed stroke volume with a non-
instantaneous thennodilution technique, and did
not observe an effect of shocks on cardiac he-
modynamics."^ Tbe second study largely used the
same biphasic waveform and transvenous lead sys-
tem in all patients.̂  This study observed tbat shocks
decrease cardiac hemodynamics, but the study de-
sign incorporated only a single measurement in
each patient at a nonuniform time between 2 and
5 minutes after each sbock."* Furthermore, shock
strengths were not reported.''
Limitations
A limitation of this study is tbat tbe absolute du-
ration of ventricular fibrillation varied depending
upon tbe shock strength. It may be that a longer
duration of ventricular fibrillation results in a more
profound effect on cardiac index. If so. it is un-
likely that a similar negative inotropic effect would
have occurred after a 27- to 34-J shock delivered
during the baseline rhytbm as during defibrillation
energy requirement testing. A second limitation is
that the mitral valve Doppler signals were only
recorded up to 4 minutes after each shock. There-
fore, the total duration of tbe adverse hemodynamic
effect of high-energy shocks during ventricular fi-
brillation was not detennined. Finally, for shocks
delivered during the baseline rhytbm, the minimum
shock energy associated with ventricular stunning
cannot be determined from this study.
Clinical Implications
Tbe results of this study have several implica-
tions for deflbrillator implantation, defibrillator pro-
gramming, and defibrillator development. First,



































































DER = defibrillation energy requirement; HR - heart rate; SR = baseline rhythm.
*P< 0.01; t P < 0.05.
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these results suggest that defihriliators should not
be routinely programmed to the maximum avail-
able energy. Lower-energy shocks that consistently
result in successful defibrillation are likely to be
associated with improved postshock hemodynam-
ics. In the present study, this was demonstrated to
be true with shocks delivered during the baseline
rhythm and during ventricular fibrillation. The same
is probably also true when defibrillator shocks are
used to treat ventricular tachycardia and supraven-
tricular tachycardias. Given that ventricular and
supraventricular tachycardias are sometimes treated
in the ventricular fibrillation zone of the implantable
defibrillator, patients probably also receive high-
output shocks for these arrhythmias. Therefore, ir-
respective of the rhythm being treated by the de-
fibrillator, if an adequate defibriiiation safety mar-
gin can be achieved with a lower energy shock,
then lower-energy defibrillation may be preferred.
Second, although the mechanism of presumed de-
fibrillation-induced congestive heart failure is not
known, these data suggest the use of lower-energy
shocks may prevent this phenomenon.''*'̂  One may
argue that a 10% reduction in cardiac index may
not be important for normal patients. However, pa-
tients with implanted defibrillators typically have
a low ejection fraction, an advanced New York
Heart Association heart failure classification, and
a reduced cardiac reserve. These frequent comor-
bidities suggest that the 10% reduction in cardiac
index after defibrillation may be clinically impor-
tant, and that the current industry direction toward
lower maximum energy defibrillators is appropri-
ate. Additionally, lower-energy defibrillation re-
sults in a shorter arrhythmia duration, which may
limit the ischemic effects of ventricular fibrillation.
Finally, these data have implications for the wait-
ing time between inductions of ventricular fibril-
lation used to determine the defibriiiation energy
requirement. During defibrillation energy require-
ment testing using a step-down protocol, a mini-
mum of 4 minutes should be allowed to elapse be-
tween inductions of ventricular fibrillation.
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